Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

305

Figures (1-4)

Sum=355

Publishing Process of This Article

Item

Count

Browse

Download

Sum=50

Aug 16, 2024 (publication date) through Jul 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 16, 2024; 12(23): 5441-5447
Published online Aug 16, 2024. doi: 10.12998/wjcc.v12.i23.5441

Full Size Figure Download Figure

Figure 1 The endoscopic view of the colon. A: Before starting tofacitinib (Mayo 3); B: After 12 weeks of dual biologic therapy (Mayo 0).

Citation: Filipiuk A, Gonciarz M. Rare extraintestinal manifestations of ulcerative colitis treated with dual biologic therapy: A case report. World J Clin Cases 2024; 12(23): 5441-5447
URL: https://www.wjgnet.com/2307-8960/full/v12/i23/5441.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i23.5441